These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Specific antibodies to halothane-induced liver antigens in halothane-associated hepatitis. Kenna JG; Neuberger J; Williams R Br J Anaesth; 1987 Oct; 59(10):1286-90. PubMed ID: 3676056 [TBL] [Abstract][Full Text] [Related]
25. Editorial: Halothane and liver damage. Br Med J; 1974 Sep; 3(5931):589-90. PubMed ID: 4423092 [No Abstract] [Full Text] [Related]
26. Increased frequency of DR2 in patients with aplastic anaemia and increased DR sharing in their parents. Chapuis B; Von Fliedner VE; Jeannet M; Merica H; Vuagnat P; Gratwohl A; Nissen C; Speck B Br J Haematol; 1986 May; 63(1):51-7. PubMed ID: 3458502 [TBL] [Abstract][Full Text] [Related]
27. Halothane hepatitis as seen by the physician. Reed WD; Williams R Br J Anaesth; 1972 Sep; 44(9):935-40. PubMed ID: 4634876 [No Abstract] [Full Text] [Related]
28. Halothane hepatitis. Neuberger J; Williams R Dig Dis; 1988; 6(1):52-64. PubMed ID: 3349642 [TBL] [Abstract][Full Text] [Related]
29. [Relevance of clinical signs of hypersensitivity in cases of halothane hepatitis]. Walton B Ann Anesthesiol Fr; 1976; 17(3):291-4. PubMed ID: 984517 [TBL] [Abstract][Full Text] [Related]
30. Halothane hepatitis in children. Kenna JG; Neuberger J; Mieli-Vergani G; Mowat AP; Williams R Br Med J (Clin Res Ed); 1987 May; 294(6581):1209-11. PubMed ID: 3109584 [TBL] [Abstract][Full Text] [Related]
31. Unexplained hepatitis following halothane. Walton B; Simpson BR; Strunin L; Doniach D; Perrin J; Appleyard AJ Br Med J; 1976 May; 1(6019):1171-6. PubMed ID: 1268612 [TBL] [Abstract][Full Text] [Related]
32. Halothane-related hepatitis. A clinical study of twenty-six cases. Moult PJ; Sherlock S Q J Med; 1975 Jan; 44(173):99-114. PubMed ID: 1153692 [TBL] [Abstract][Full Text] [Related]
33. Enflurane hepatitis. A report of a case with a previous history of halothane hepatitis. Sigurdsson J; Hreidarsson AB; Thjodleifsson B Acta Anaesthesiol Scand; 1985 Jul; 29(5):495-6. PubMed ID: 4036534 [TBL] [Abstract][Full Text] [Related]
34. Halothane hepatitis: a critical review. Carney FM; Van Dyke RA Anesth Analg; 1972; 51(1):135-60. PubMed ID: 4399967 [No Abstract] [Full Text] [Related]
35. [Mechanism of drug-induced hepatitis. A consequence of superposition of two xenobiotic systems]. Pessayre D Gastroenterol Clin Biol; 1995; 19(5 Pt 2):B47-56. PubMed ID: 8522102 [No Abstract] [Full Text] [Related]
37. HLA-DR/DQ antigens and reactivity to B cell alloantigen D8/17 in Indian patients with rheumatic heart disease. Taneja V; Mehra NK; Reddy KS; Narula J; Tandon R; Vaidya MC; Bhatia ML Circulation; 1989 Aug; 80(2):335-40. PubMed ID: 2787710 [TBL] [Abstract][Full Text] [Related]
38. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. Singh SP; Mehra NK; Dingley HB; Pande JN; Vaidya MC J Infect Dis; 1983 Oct; 148(4):676-81. PubMed ID: 6415179 [TBL] [Abstract][Full Text] [Related]
39. Genetic markers in narcolepsy. Langdon N; Welsh KI; van Dam M; Vaughan RW; Parkes D Lancet; 1984 Nov; 2(8413):1178-80. PubMed ID: 6150235 [TBL] [Abstract][Full Text] [Related]